EUVIMEDOpdag EUVIMED
Crossref

Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer

Masaaki Nishi, Yuma Wada, Chie Takasu, Takuya Tokunaga, Toshihiro Nakao, Hideya Kashihara, Toshiaki Yoshimoto, Mitsuo Shimada

World Journal of Surgery · 2026-06 · 50 (6) · 1631-1638

DOI: 10.1002/wjs.70372 ↗

At a glance

Journal article in World Journal of Surgery, published online on 2026-04-16. Written by Masaaki Nishi and 7 co-authors. Institution: Department of Surgery, University of Tokushima Graduate School, Tokushima, Japan. Major MEDLINE topics: Antineoplastic Combined Chemotherapy Protocols, Gastrectomy, Immune Checkpoint Inhibitors, Stomach Neoplasms. Cited 1 times so far (Crossref); 33 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aim

Conversion surgery (CS) for unresectable advanced gastric cancer (GC; clinical stage IVb) has increased in recent years owing to advances in drug therapy. However, little is known about CS following combination treatment with immune checkpoint inhibitors (ICIs) and chemotherapy.

Methods

We conducted a retrospective cohort study of patients initially unresectable metastatic GC. We treated 36 patients with initially unresectable metastatic GC. Thirty‐four patients received combination treatment with ICIs and chemotherapy, 11 of whom underwent CS. We evaluated their short‐term and long‐term surgical outcomes.

Results

Among patients who underwent CS, six were male and five female, and the median (interquartile range) age was 71 (47–75) years. All patients started first‐line therapy with S‐1 plus oxaliplatin combined with nivolumab, and two patients underwent surgery after second‐line treatment with ramucirumab and nanoparticle albumin‐bound paclitaxel. There were four open, two laparoscopic, and five robotic surgeries. The median operative time was 348 (321–354) minutes, blood loss was 16 (10–30) mL, and number of retrieved lymph nodes was 38 (27–44); there were no cases of conversion to laparotomy. R0 resection was achieved in all patients. And postoperative pathology was complete response; three patients, ypStage I; four patients, II; three patient, III; zero patient IV; one patient. ICI and chemotherapy efficacy was Grade 1 in four patients, Grade 2 in two patients, and Grade 3 in five patients. Overall 2‐year survival was 90.0% for those who underwent CS.

Conclusion

CS following combination treatment with ICI and chemotherapy may be promising for initially unresectable metastatic GC.

Subjects

MeSH terms (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsGastrectomyImmune Checkpoint InhibitorsStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedAntibodies, Monoclonal, HumanizedCombined Modality TherapyDrug CombinationsNeoplasm StagingNivolumabOxaliplatinOxonic AcidPaclitaxelRamucirumabRetrospective StudiesRobotic Surgical ProceduresTegafurTreatment Outcome

Author keywords

chemotherapyconversion surgerygastric cancerimmune check point inhibitormetastasis

Substances

Antibodies, Monoclonal, HumanizedDrug CombinationsImmune Checkpoint InhibitorsNivolumabOxaliplatinOxonic AcidPaclitaxelRamucirumabS 1 (combination)Tegafur

Authors and institutions

  • Department of Surgery, University of Tokushima Graduate School, Tokushima, Japan.

Cite

APA

Nishi, M., Wada, Y., Takasu, C., Tokunaga, T., Nakao, T., Kashihara, H., Yoshimoto, T., & Shimada, M. (2026). Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer. World Journal of Surgery, 50(6), 1631-1638. https://doi.org/10.1002/wjs.70372

Vancouver

Nishi M, Wada Y, Takasu C, Tokunaga T, Nakao T, Kashihara H, et al. Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer. World Journal of Surgery. 2026;50(6):1631-1638. doi:10.1002/wjs.70372

BibTeX
@article{Nishi2026,
  author = {Nishi, Masaaki and Wada, Yuma and Takasu, Chie and Tokunaga, Takuya and Nakao, Toshihiro and Kashihara, Hideya and Yoshimoto, Toshiaki and Shimada, Mitsuo},
  title = {Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer},
  journal = {World Journal of Surgery},
  year = {2026},
  volume = {50},
  number = {6},
  pages = {1631--1638},
  doi = {10.1002/wjs.70372}
}
Start for free →